China Resources Pharmaceutical Group Ltd. 3320

HKEX · Hong Kong SAR China · Health Technology

HKD 4.45+0.09 (+2.06%)

Market closed· Sep 30, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

China Resources Pharmaceutical Group Ltd. 3320

HKEX · Hong Kong SAR China · Health Technology

HKD 4.45+0.09 (+2.06%)

Market closed· Sep 30, 2026, 8:08 AM UTC· HKD · Data may be delayed

Prices may be delayed and are for informational purposes only - not investment advice.

-21.93% · 6MFull-screen chart

Open HKD 4.38High HKD 4.47Low HKD 4.34Close HKD 4.45Volume 9.13M

Sep 30, 2026

Charts by TradingView Lightweight Charts

Key statistics

Previous close: HKD 4.36
Day range: HKD 4.35 – HKD 4.47
52-week range: HKD 4.22 – HKD 6.53
Volume: 9.14M
Market cap: HKD 27.96B
P/E (TTM): 6.0
Dividend yield (annualized): 4.90%
Next earnings date: 2027-03-24
Avg. volume (1Y): 12.67M

Performance

1 week

+1.95%

1 month

+1.85%

3 months

+4.18%

6 months

-24.08%

Year to date

+4.03%

1 year

-2.46%

Total return, dividends included.

Company profile

Sector: Health Technology
Industry: Pharmaceuticals: Major
Country: Hong Kong SAR China
Exchange: HKEX
Shares outstanding: 6.28B
Employees: 85,600
ISIN: HK0000311099
Beta: 0.39

Technical view

Below averages

Where the price sits against its 50- and 200-day moving averages.

Valuation & analysis

Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.

News

Yahoo FinanceApr 12, 2026

AilsynBio and Dong-E-E-Jiao Sign Project Cooperation Agreement Empowering Traditional Medicine with AI to Open a New Chapter in the Health Industry

Hong Kong, SAR--(Newsfile Corp. - April 12, 2026) - AilsynBio, an AI-driven drug discovery company, held an Innovative Project Cooperation Agreement Signing Ceremony today at the Hong Kong Science Park, announcing a project cooperation agreement with Dong-E-E-Jiao Co., Ltd. (SZSE: 000423). This partnership marks a profound cross-sector integration of Artificial Intelligence (AI) and traditional medicine, aiming to empower biopharmaceutical innovation through technological means.The ceremony...

Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.